HOME >> BIOLOGY >> NEWS
Cognitive testing reduces risks of procedure for brain arteriovenous malformations

Imagine dropping a bowl of spaghetti. That's what AVMs (arteriovenous malformations) look like in the brain -- dense clusters of twisting and turning blood vessels that look more like a wrestling match among a hundred small snakes than part of the circulatory system. Many patients don't know they have one. Some have crippling headaches. For the more unfortunate, the AVM ruptures, causing brain damage or death.

Now, a team of Johns Hopkins specialists has developed a relatively simple and safe way to locate the right vessels to surgically seal off, or embolize, greatly reducing the risk of causing inadvertent damage to vital brain tissue.

In a study of 29 procedures performed on 14 patients, published in the March edition of the American Journal of Neuroradiology, the scientists used a microcatheter to administer sodium amobarbital (a sedative) one at a time to each of the vessels supplying blood to the AVM. By anesthetizing each area of the brain fed by each vessel, they essentially mimicked what would occur in a particular brain area if blood flow was blocked by sealing the vessel with N-butyl cyanoacrylate glue.

Currently, the standard treatment is to seal off the feeder vessels to the AVM with the glue without physicians being able to tell in advance if the vessels they are blocking will cause irreversible damage to the brain tissue fed by the vessels. Seven percent to 39 percent of patients experience post-operative brain damage and as many as 3 percent of patients die, according to Kieran Murphy, M.D., director of Hopkins' interventional neuroradiology program and one of the study's authors.

"This approach represents a major improvement in treatment," Murphy says. "It provides a relatively easy and accurate way to pinpoint the vessels feeding the AVM that can be safely embolized, and more importantly, those that need to be left alone in order to avoid brain damage."

Testing revealed that in 12 of the 14 patie
'"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
1-Mar-2002


Page: 1 2

Related biology news :

1. Cognitive performance influenced by gene for prion protein (also affected by mad cow disease)
2. Good News: Cognitive decline after bypass surgery mostly temporary and reversible
3. Cognitive therapy for schizophrenia: Hope for those whom drugs havent helped
4. Cognitive abilities increase significantly with time in most prematurely born children
5. Study Finds Evidence Linking The Brains Cognitive Control Regions With Stress Control Regions
6. Far more men than women favor routine paternity testing at birth
7. Nucleic acid-amplification testing further safeguards nations blood supply
8. Clinical judgement still counts strongly alongside genetic testing
9. Genetic testing of embryos to pick savior sibling OK with most Americans
10. Annual bioethics forum to explore genetic testing
11. New toxicity test could cut animal testing

Post Your Comments:
(Date:5/22/2013)... Harvard physicists have developed a novel technique that can ... a process that is one of the most important, ... described in a paper in Nature , post-doctoral ... Dr. Melanie Schnell of the Center for Free-Electron Laser ... relies on finely-tuned microwave fields to identify molecular variants ...
(Date:5/22/2013)... 3 fatty acids in fish oil have long been ... the American Heart Association currently recommends eating at least ... rich in omega 3s. However, the mechanism behind this ... study, scientists led by Jason R. Carter of Michigan ... evidence that fish oil might specifically counteract the detrimental ...
(Date:5/22/2013)... and human health effects from disposal of millions ... scientists to recommend stronger government policies to encourage ... materials. That,s the conclusion of a new paper ... Technology . , Oladele A. Ogunseitan and colleagues ... for powering everything from smart phones to components ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
(Date:5/23/2013)... May 23, 2013 BioTrends Research Group, ... firms for specialized biopharmaceutical issues, finds that, unaided, ... disease specialists reported that in the past six ... delaying treatment) in anticipation of the next generation ... ago, when only 6 percent reported that they ...
(Date:5/23/2013)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... personalized immune therapies for solid tumor cancers, announced today ... American Society Of Clinical Oncology (ASCO) meeting in ... in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... pre-eminent conference focused on clinical treatment of cancer, with ...
(Date:5/23/2013)... -- Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced that Jeffrey ... two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ) ... Annual Marcum LLP Microcap Conference on Thursday, May 30, ... City.  The presentation is scheduled to begin at 4:30 ...
(Date:5/23/2013)... SynCardia Systems, Inc. ( http://www.syncardia.com ), manufacturer ... and CE (Europe) approved Total Artificial Heart, announced today ... more than 380,000 visitors annually, is featuring the ... Freedom® portable driver as part of its $3 million ... its kind. , “BodyWorks combines the latest technology ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
Cached News: